Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CYTH - Cyclo Therapeutics Inc - Ordinary Shares - Class A


IEX Last Trade
0.7401
-0.030   -4.026%

Share volume: 138,137
Last Updated: Fri 30 Aug 2024 09:59:24 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.77
-0.03
-3.87%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-4.14%
1 Month
-31.40%
3 Months
-42.48%
6 Months
-54.68%
1 Year
-51.13%
2 Year
-64.05%
Key data
Stock price
$0.74
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.70 - $2.12
52 WEEK CHANGE
-$0.54
MARKET CAP 
21.456 M
YIELD 
N/A
SHARES OUTSTANDING 
28.696 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.78
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$159,956
AVERAGE 30 VOLUME 
$72,572
Company detail
CEO:
Region: US
Website: ctd-holdings.com
Employees: 16
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

cyclodextrin technologies development, inc. (ctd), the "company"​, was organized as a florida corporation on august 9, 1990 with operations beginning july, 1992. in may of 1994 the company became a fully reporting public company listed on the otc bb under the symbol ctdi. in 2000, the company altered its corporate structure to a holding company with subsidiary companies. the otc bb symbol was changed to ctdh. ctd holdings, inc. (the "company"​) was originally formed to market and sell cyclodextrins and related products to the food, pharmaceutical, and other industries; it also provided consulting services related to cyclodextrin technology. ctdh, as a holding company, will acquire, create, and invest in companies that will develop, market, and/or sell products containing cyclodextrins. the company currently operates four wholly owned subsidiaries: ctd, inc.; nanosonic products, inc.; sphingo biotech, inc.; and ferrazo environmental technologies, inc.

Recent news